Sunitinib

From Libre Pathology
Revision as of 14:49, 30 May 2016 by Michael (talk | contribs)
Jump to navigation Jump to search

Sunitinib (marketed with the brand name Sutent) is a tyrosine kinase inhibitor used to treat renal cell carcinoma (RCC).

In RCC acts on:[1]

  • VEGF.
  • PDGFbeta.

See also

References

  1. ↑ Toon, CW.; Hasovits, C.; Paik, J.; Field, M.; Chou, A.; Hugh, TJ.; Pavlakis, N.; Gill, AJ. (Jul 2014). "Skin rash, a kidney mass and a family mystery dating back to World War II.". Med J Aust 201 (1): 58-60. PMID 24999901.
Retrieved from "https://librepathology.org/w/index.php?title=Sunitinib&oldid=44709"